Pure Global

LIFOTRONIC Free Prostate Specific Antigen (eCLlA) - Indonesia BPOM Medical Device Registration

LIFOTRONIC Free Prostate Specific Antigen (eCLlA) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20306320363. The device is manufactured by SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD. from China, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is LIFOTRONIC TECHNOLOGY INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
LIFOTRONIC Free Prostate Specific Antigen (eCLlA)
Analysis ID: AKL 20306320363

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

LIFOTRONIC TECHNOLOGY INDONESIA

AR Address

Ruko South Goldfinch Blok SGA No. 17, Jl. Spring Boulevard, Kode Pos 15322, Kel. Cihuni, Kec. Pagedangan, Kab. Tangerang, Provinsi Banten

Registration Date

Dec 13, 2023

Expiry Date

Mar 13, 2028

Product Type

Tumor Antigen Immunologic Test System

Tumor-associated antigen immunological test system.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing